Atlas Trials

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

Clinical trial NCT00196716 · COMPLETED

Trial details

NCT number
NCT00196716
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Fabry Disease
Start date
2003-06-01
Primary completion
2006-04-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.